< Back to previous page
Project
Seeing is believing: Unraveling inflammation processes in auto-immune diabetes with non-invasive imaging.
Type 1 diabetes is an auto-immune disease in which the pancreatic beta-cells become selectively destroyed. In this project we aim to develop novel 19F MRI contrast agents which would enable in vivo kwantification of the developed immune responses. We will verify the selectivity and specificity of the developed contrast agents.
Date:1 Jan 2014 → 31 Dec 2019
Keywords:perfluorocarbon nanoparticles, 19F MRI, diabetes
Disciplines:Medical imaging and therapy, Drug discovery and development, Pharmacotherapy, Pharmaceutics, Pharmacology, Endocrinology and metabolic diseases, Biomarker discovery and evaluation, Other pharmaceutical sciences, Medicinal products, Other paramedical sciences, Pharmacognosy and phytochemistry, Toxicology and toxinology